Volume 27, Issue 3 (Avicenna Journal of Clinical Medicine-Autumn 2020)                   Avicenna J Clin Med 2020, 27(3): 133-139 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yanangi M, Artimani T, Sajedi N, Poorolajal J, Pour Monsef F. Comparison of the Activated Peripheral Blood Mononuclear Cells with Human Placental Gonadotropin Method with Platelet-Rich Plasma on Pregnancy Success Rate after Embryo Transfer. Avicenna J Clin Med. 2020; 27 (3) :133-139
URL: http://sjh.umsha.ac.ir/article-1-2120-en.html
1- Associate Professor of Obstetrics and Gynecology Endometrium and Endometriosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2- Associate Professor of Reproductive Biology Endometrium and Endometriosis Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3- Resident Candidate in Obstetrics and Gynecology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , nargessajedi98@gmail.com
4- Assistant Professor, Department of Epidemiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
5- BSc in Midwifery, Fatemieh Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract:   (952 Views)
Background and Objective: According to the results of some studies, peripheral blood mononuclear cells activated with human placental gonadotropin increase the success rate of pregnancy in infertile women. This study aimed to compare the effect of two treatment methods of peripheral blood mononuclear cells activated with human placental gonadotropin and platelet-rich plasma on the success rate of pregnancy after embryo transfer.
Materials and Methods: This randomized clinical trial was conducted on 40 females with repeated implantation failure who were candidates for in vitro fertilization (IVF) and referred to Fatemieh Hospital, Hamadan, Iran, in 2019. Subsequently, they were randomly assigned to two groups of A and B. Peripheral blood mononuclear cells activated with human placental gonadotropin were utilized in group A, and group B received platelet-rich plasma autologous blood before transfusion. The incidence of chemical and clinical pregnancies was measured in both groups. Moreover, the data were analyzed in Stata software (version 14), and a p-value less than 0.05 was considered statistically significant.
Results: The mean ages and duration of the infertility of the females were 32.5 and 34.4 years (P=0.203), as well as 9.1 and 8.5 years (P=0.747) in groups A and B, respectively. Moreover, the mean numbers of the obtained ovum, embryos formed, and transferred embryos were 15.4±11.5 and 12.9±8.9 (P=0.439), 7.1±6.2 and 5.8±3.8 (P=0.427), as well as 2.3±0.7 and 2.3±0.6 (P=1.00) in groups A and B, respectively. Furthermore, the rates of chemical pregnancies were 15% and 25% (P=0.619), and clinical pregnancies were 15% and 20% (P=0.581) in groups A and B, respectively.
Conclusion: The administration of human placental gonadotropin-activated peripheral blood cells showed similar results on pregnancy outcome with platelet-rich plasma after an embryo transfer in females who were candidates for IVF with repeated implantation failure.
 
Full-Text [PDF 1160 kb]   (398 Downloads)    
Type of Study: Original | Subject: Obstetrics & Gynecology

References
1. Kovac JR, Smith RP, Cajipe M, Lamb DJ, Lipshultz LI. Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction. Asian J Androl. 2017;19(1):39-42. PMID: 27751992 DOI: 10.4103/1008-682X.189211
2. Gurunath S, Pandian Z, Anderson RA, Bhattacharya S. Defining infertility-a systematic review of prevalence studies. Hum Reprod Update. 2011;17(5):575-88. PMID: 21493634 DOI: 10.1093/humupd/dmr015
3. Akhondi MM, Ranjbar F, Shirzad M, Ardakani ZB, Kamali K, Mohammad K. Practical difficulties in estimating the prevalence of primary infertility in Iran. Int J Fertil Steril. 2019;13(2):113-7. PMID: 31037921 DOI: 10.22074/ijfs.2019.5583
4. Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci. 2015;8(4):191-6. PMID: 26752853 DOI: 10.4103/0974-1208.170370
5. Abrao MS, Muzii L, Marana R. Anatomical causes of female infertility and their management. Int J Gynaecol Obstet. 2013;123(Suppl 2):S18-24. PMID: 24119894 DOI: 10.1016/j.ijgo.2013.09.008
6. Khizroeva J, Nalli C, Bitsadze V, Lojacono A, Zatti S, Andreoli L, et al. Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101369. PMID: 31837981 DOI: 10.1016/j.beem.2019.101369
7. Frith L, Blyth E. Assisted reproductive technology in the USA: Is more regulation needed? Reprod Biomed Online. 2014;29(4):516-23. PMID: 25171854 DOI: 10.1016/j.rbmo.2014.06.018
8. Wise J. Assisted reproductive technology has low complication risk, US data show. BMJ. 2015;350:h37. PMID: 25567128 DOI: 10.1136/bmj.h37
9. Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Report Biomed Online. 2014;28(1):14-38. PMID: 24269084 DOI: 10.1016/j.rbmo.2013.08.011
10. Bellinge BS, Copeland CM, Thomas TD, Mazzucchelli RE, O’Neil G, Cohen MJ. The influence of patient insemination on the implantation rate in an in vitro fertilization and embryo transfer program. Fertil Steril. 1986;46(2):252-6. PMID: 3732531 DOI: 10.1016/s0015-0282(16)49521-x
11. Yoshinaga K. Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system. Semin Cell Dev Biol. 2008;19(2):161-9. PMID: 18054836 DOI: 10.1016/j.semcdb.2007.10.006
12. Okitsu O, Kiyokawa M, Oda T, Miyake K, Sato Y, Fujiwara H. Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J Reprod Immunol. 2011;92(1-2):82-7. PMID: 22035703 DOI: 10.1016/j.jri.2011.07.001
13. De Groote D, Zangerlé PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 1992;4(3):239-48. PMID: 1498259 DOI: 10.1016/1043-4666(92)90062-v
14. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus. Eur J Immunol. 1993;23(1):224-31. DOI: 10.1002/eji.1830230135
15. Chaka W, Verheul AF, Vaishnav VV, Cherniak R, Scharringa J, Verhoef J, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol. 1997;159(6):2979-85. PMID: 9300722
16. Kobayashi M, Kawase T, Okuda K, Wolff LF, Yoshie H. In vitro immunological and biological evaluations of the angiogenic potential of platelet-rich fibrin preparations: a standardized comparison with PRP preparations. Int J Implant Dent. 2015;1(1):31. PMID: 27747653 DOI: 10.1186/s40729-015-0032-0
17. Etulain J, Mena HA, Meiss RP, Frechtel G, Gutt S, Negrotto S, et al. An optimised protocol for platelet-rich plasma preparation to improve its angiogenic and regenerative properties. Sci Rep. 2018;8(1):1513. PMID: 29367608 DOI: 10.1038/s41598-018-19419-6
18. Farimani M, Bahmanzadeh M, Poorolajal J. A new approach using autologous platelet-rich plasma to treat infertility and to improve population replacement rate. J Res Health Sci. 2016;16(3):172-3. PMID: 27840348
19. Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017;21(1):54-6. PMID: 28333034 DOI: 10.5935/1518-0557.20170013
20. Nazari L, Salehpour S, Hosseini MS, Hashemi Moghanjoughi P. The effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial. Hum Fertil. 2019;23(3):209-13. PMID: 30714427 DOI: 10.1080/14647273.2019.1569268
21. Nakayama T, Fujiwara H, Maeda M, Inoue T, Yoshioka S, Mori T, et al. Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: HCG enhances the effects of PBMC. Hum Reprod. 2002;17(1):207-12. PMID: 11756389 DOI: 10.1093/humrep/17.1.207
22. Yoshioka S, Fujiwara H, Nakayama T, Kosaka K, Mori T, Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF–embryo transfer. Hum Reprod. 2006;21(12):3290-4. PMID: 17021188 DOI: 10.1093/humrep/del312
23. Abasalizadeh M, Nehzati P, Allahbakhshian M, Hamidpour M, Khadem Mabudi AA, Tabatabaie MR. The detection of Scavenger Receptor-B1 expression and its role on the function of platelets in patients with atherosclerotic disease. Sci J Iran Blood Trans Organ. 2017;14(2):92-100.
24. Yu N, Zhang B, Xu M, Wang S, Liu R, Wu J, et al. Intrauterine administration of autologous peripheral blood mononuclear cells (PBMC s) activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study. Am J Reprod Immunol. 2016;76(3):212-6. DOI: 10.1111/aji.12542
25. Li S, Wang J, Cheng Y, Zhou D, Yin T, Xu W, et al. Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J Reprod Immunol. 2017;119:15-22. PMID: 27915038 DOI: 10.1016/j.jri.2016.11.006
26. Nazari L, Salehpour S, Hoseini S, Zadehmodarres S, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: a pilot study. Int J Reprod Biomed. 2016;14(10):625-8. PMID: 27921085
27. Lee JW, Kwon OH, Kim TK, Cho YK, Choi KY, Chung HY, et al. Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups. Arch Plast Surg. 2013;40(5):530-5. PMID: 24086805 DOI: 10.5999/aps.2013.40.5.530
28. Stellos K, Seizer P, Bigalke B, Daub K, Geisler T, Gawaz M. Platelet aggregates-induced human CD34+ progenitor cell proliferation and differentiation to macrophages and foam cells is mediated by stromal cell derived factor 1 invitro. Semin Thromb Hemost. 2010;36(2):139-45. PMID: 20414828

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb